Your browser doesn't support javascript.
loading
Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial.
Zhao, Xianzhi; Xiao, Yu-Tian; Yang, Yue; Ye, Yusheng; Chang, Yifan; Jiang, Lingong; Eftekhar, Md; Ren, Shancheng; Zhang, Huojun.
Afiliação
  • Zhao X; Department of Radiation Oncology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Xiao YT; Department of Urology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Yang Y; Department of Urology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Ye Y; Department of Radiation Oncology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Chang Y; Department of Urology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Jiang L; Department of Radiation Oncology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
  • Eftekhar M; Department of Family Medicine, CanAm International Medical Center, Shenzhen, China.
  • Ren S; Department of Urology, Shanghai Changzheng Hospital, 56652Naval Medical University, Shanghai, China.
  • Zhang H; Department of Radiation Oncology, Shanghai Changhai Hospital, 12520Naval Medical University, Shanghai, China.
Cancer Control ; 29: 10732748221120462, 2022.
Article em En | MEDLINE | ID: mdl-35980734

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Guideline / Observational_studies / Qualitative_research Limite: Humans / Male Idioma: En Revista: Cancer Control Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Guideline / Observational_studies / Qualitative_research Limite: Humans / Male Idioma: En Revista: Cancer Control Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China